SCHEMBL7329520

SCHEMBL7329520

O=C(O)c1ncn2c1c(C(=O)N1CCCC1)cc1ccccc12

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.43
CYP2C9 P11712 2/20 0.41
TSHR P16473 4/20 0.40
GNE Q9Y223 1/20 0.40
RECQL P46063 1/20 0.40
HPGD P15428 4/20 0.40
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 1/20 0.40
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
POLB P06746 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7337972 0.85 GABRA1 (0.38) HSD17B10HPGD
SCHEMBL29729255 0.72 CYP2C9 (0.51) HSD17B10CYP2C9HPGDALDH1A1KDM4E
SCHEMBL9773340 0.65 PTPN2 (0.46) HSD17B10TSHRRECQLHPGDALDH1A1
SCHEMBL6474233 0.65 HPGD (0.63) CYP2C9TSHRHPGDALDH1A1KDM4E
SCHEMBL4827189 0.65 ALDH1A1 (0.69) TSHRRECQLHPGDALDH1A1MEN1
SCHEMBL6479981 0.65 MAPT (0.62) HSD17B10RECQLHPGDALDH1A1KDM4E
SCHEMBL9657485 0.64 GABRA5 (0.54) HSD17B10TSHRHPGDALDH1A1KDM4E
SCHEMBL10720608 0.64 TSHR (0.69) TSHRRECQLHPGDALDH1A1KDM4E
SCHEMBL3901397 0.64 IDO1 (0.54) HSD17B10TSHRRECQLHPGDALDH1A1
SCHEMBL16051336 0.64 ALDH1A1 (0.67) TSHRRECQLHPGDALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729469-A1 IMIDAZO [1,5-a]QUINOLINES FOR TREATMENT OF ANXIETY AND SLEEP DISORDERS PHARMACIA & UPJOHN COMPANY (US) 1996-09-04 EP disclosed
WO-1995014020-A1 IMIDAZO[1,5-a]QUINOLINES FOR TREATMENT OF ANXIETY AND SLEEP DISORDERS THE UPJOHN COMPANY (US) 1995-05-26 WO disclosed